Bethesda, Maryland, USA, 14 November 2024 - A landmark paper by distinguished neuroendocrine psychiatrist Dr. Philip W. Gold, published in Brain Medicine's Seymour Reichlin Centenary Festschrift ...

The global neuroendocrine carcinoma treatment market is poised for substantial growth, with revenue expected to reach USD ...

A Fort Wright mom of four battling an extremely rare cancer is now helping in the fight for a cure. Five years ago, Kristy ...

The firm says that with paltusotine’s Phase 3 for carcinoid syndrome set to kick off before year-end, Crinetics unveils a new asset for neuroendocrine tumors. Crinetics again demonstrated its “drug ...

In a report released yesterday, Cory Jubinville, PhD from LifeSci Capital maintained a Buy rating on Crinetics Pharmaceuticals (CRNX – ...

A research team has shown that that combining pembrolizumab, an immunotherapy drug, with standard chemotherapy can improve treatment outcomes for patients with small cell bladder cancer and small cell ...

BOSTON, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare ...

A research team led by UCLA Health Jonsson Comprehensive Cancer Center investigators has shown that that combining ...

The mum-of-two said it was after she passed blood that she was sent for tests that found she had a "low-grade" neuroendocrine ...

Olivia Williams says she has become more blunt and courageous following her neuroendocrine cancer diagnosis in 2018.

A PA Student used his experience in the military, and his own health journal, to help other veterans apply and receive ...

Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today ...